Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Department of Cardiothoracic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
J Am Coll Cardiol. 2023 Oct 10;82(15):1512-1520. doi: 10.1016/j.jacc.2023.08.006.
Heart transplantation using donation after circulatory death (DCD) allografts is increasingly common, expanding the donor pool and reducing transplant wait times. However, data remain limited on clinical outcomes.
We sought to compare 6-month and 1-year clinical outcomes between recipients of DCD hearts, most of them recovered with the use of normothermic regional perfusion (NRP), and recipients of donation after brain death (DBD) hearts.
We conducted a single-center retrospective observational study of all adult heart-only transplants from January 2020 to January 2023. Recipient and donor data were abstracted from medical records and the United Network for Organ Sharing registry, respectively. Survival analysis and Cox regression were used to compare the groups.
During the study period, 385 adults (median age 57.4 years [IQR: 48.0-63.7 years]) underwent heart-only transplantation, including 122 (32%) from DCD donors, 83% of which were recovered with the use of NRP. DCD donors were younger and had fewer comorbidities than DBD donors. DCD recipients were less often hospitalized before transplantation and less likely to require pretransplantation temporary mechanical circulatory support compared with DBD recipients. There were no significant differences between groups in 1-year survival, incidence of severe primary graft dysfunction, treated rejection during the first year, or likelihood of cardiac allograft vasculopathy at 1 year after transplantation.
In the largest single-center comparison of DCD and DBD heart transplantations to date, outcomes among DCD recipients are noninferior to those of DBD recipients. This study adds to the published data supporting DCD donors as a safe means to expand the heart donor pool.
使用心跳停止后捐献(DCD)供体的心脏移植越来越普遍,这扩大了供体池并缩短了移植等待时间。然而,关于临床结果的数据仍然有限。
我们旨在比较使用常温区域性灌注(NRP)复苏的 DCD 心脏受者和脑死亡(DBD)心脏受者的 6 个月和 1 年临床结局。
我们对 2020 年 1 月至 2023 年 1 月期间进行的所有成人心脏移植的单中心回顾性观察性研究进行了分析。分别从病历和美国器官共享网络登记处提取受者和供者的数据。采用生存分析和 Cox 回归比较两组。
在研究期间,385 名成年人(中位年龄 57.4 岁[IQR:48.0-63.7 岁])接受了心脏移植,其中 122 名(32%)来自 DCD 供体,其中 83%使用 NRP 复苏。DCD 供体比 DBD 供体更年轻,合并症更少。与 DBD 受者相比,DCD 受者在移植前住院的次数更少,在移植前需要临时机械循环支持的可能性也更小。两组间 1 年生存率、严重原发性移植物功能障碍发生率、第一年治疗性排斥反应发生率以及移植后 1 年心脏移植物血管病发生率均无显著差异。
在迄今最大的 DCD 和 DBD 心脏移植的单中心比较中,DCD 受者的结局并不劣于 DBD 受者。这项研究增加了支持 DCD 供体作为扩大心脏供体池的安全手段的已发表数据。